Inosine
Alternative Names: AxosineLatest Information Update: 05 Nov 2021
Price :
$50 *
At a glance
- Originator Childrens Hospital Boston
- Class Purine nucleosides; Ribonucleosides; Small molecules
- Mechanism of Action Nerve growth factor stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Brain injuries; Spinal cord injuries; Stroke
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Brain injuries in USA (IV, Infusion)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Spinal-cord-injuries in USA (IV, Infusion)
- 16 Jul 2016 No recent reports of development identified for preclinical development in Stroke in USA (IV, Infusion)